A Phase 2, Randomized, Double-Blind Trial to Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Pneumococcal Conjugate Vaccine In Healthy Infants

Project: Research project

Project Details

StatusActive
Effective start/end date6/28/24 → 6/27/27

Funding

  • Pfizer, Inc ( Award # ): $15,570.00